AngioDynamics, Inc. (ANGO)
15.40
+0.16
(+1.05%)
USD |
NASDAQ |
Sep 11, 15:41
AngioDynamics Gross Profit (TTM) : 164.21M for May 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| May 31, 2026 | 164.21M |
| February 28, 2026 | 159.78M |
| November 30, 2025 | 157.23M |
| August 31, 2025 | 152.44M |
| May 31, 2025 | 147.39M |
| February 28, 2025 | 143.70M |
| November 30, 2024 | 140.01M |
| August 31, 2024 | 139.37M |
| May 31, 2024 | 141.65M |
| February 29, 2024 | 147.66M |
| November 30, 2023 | 150.85M |
| August 31, 2023 | 154.42M |
| May 31, 2023 | 155.46M |
| February 28, 2023 | 155.10M |
| November 30, 2022 | 153.03M |
| August 31, 2022 | 148.42M |
| May 31, 2022 | 146.27M |
| February 28, 2022 | 142.69M |
| November 30, 2021 | 143.24M |
| August 31, 2021 | 143.16M |
| May 31, 2021 | 138.65M |
| February 28, 2021 | 126.14M |
| November 30, 2020 | 127.18M |
| August 31, 2020 | 128.61M |
| May 31, 2020 | 132.15M |
| Date | Value |
|---|---|
| February 29, 2020 | 143.52M |
| November 30, 2019 | 141.74M |
| August 31, 2019 | 140.77M |
| May 31, 2019 | 138.94M |
| February 28, 2019 | 137.17M |
| November 30, 2018 | 144.92M |
| August 31, 2018 | 147.46M |
| May 31, 2018 | 152.08M |
| February 28, 2018 | 156.74M |
| November 30, 2017 | 154.91M |
| August 31, 2017 | 157.05M |
| May 31, 2017 | 160.71M |
| February 28, 2017 | 157.87M |
| November 30, 2016 | 157.08M |
| August 31, 2016 | 156.73M |
| May 31, 2016 | 153.69M |
| February 29, 2016 | 156.56M |
| November 30, 2015 | 154.63M |
| August 31, 2015 | 156.78M |
| May 31, 2015 | 159.84M |
| February 28, 2015 | 162.78M |
| November 30, 2014 | 166.47M |
| August 31, 2014 | 164.54M |
| May 31, 2014 | 161.93M |
| February 28, 2014 | 159.05M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Boston Scientific Corp. | 13.93B |
| Penumbra, Inc. | 1.004B |
| Abbott Laboratories | 24.60B |
| Alphatec Holdings, Inc. | 500.18M |
| AtriCure, Inc. | 431.62M |